Ketamine Gets Controversial FDA Approval for Depression Treatment SciShow News

The video discusses treatment resistant depression and the FDA's approval of a new antidepressant, esketamine, which acts quickly and may help long-term. Despite promising results, concerns about its efficacy and cost remain. Additionally, recent studies suggest ultrasound could treat inflammatory and metabolic disorders by stimulating nerves, offering a non-invasive alternative to current methods. Both treatments highlight the potential for innovative approaches in addressing complex medical issues.

What potential does ultrasound therapy have in treating inflammatory and metabolic disorders?

Discuss the significance of the studies conducted on ultrasound treatment in mice and rats.

What are the implications of the findings regarding ultrasound therapy for future medical treatments?